Chungcheongbuk-Do
South Korea
3
2021-10-21
3
2022-11-01
These are the the leading inventors for applications assigned to Mediogen Co., Ltd.:
Mediogen Co., Ltd. based in Chungcheongbuk-Do, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Human-derived MG4231 or MG4244 strain having anti-obesity activity, and composition comprising same
#2 | 2021-01-28 ✅ Patent 11,738,057 granted on 2023-08-29having blood glucose lowering effect and antioxidant effect
#3 | 2020-11-05 ✅ Patent 11,857,580 granted on 2024-01-02having antimicrobial effect on and
Also check out MEDIOGEN CO., LTD.'s (Chungcheongbuk-do, South Korea) applicant profile with 3 patent applications submitted.
348749 ⎘